Home » Topics » BioWorld Science

BioWorld Science
RSS

Chiesi Farmaceutici synthesizes new LPAR2 antagonists

July 8, 2021

Shaanxi Synthetic Pharmaceutical identifies new antibacterials

July 8, 2021

Roche discloses BRAF mutant inhibitors

July 8, 2021

Chinese researchers patent claudin 18.2-targeting ADCs

July 8, 2021

SciSparc to initiate phase II study of SCI-110 in patients with AD and agitation

July 8, 2021

Scientists describe new model of primary sclerosing cholangitis-associated cholangiocarcinoma

July 8, 2021

Dual GIP/GLP-1 receptor agonist HISHS-2001 displays efficacy in type 2 diabetes model

July 8, 2021

New TGF-beta inhibitor KS-356 improves experimental obesity, hepatic steatosis

July 8, 2021

Novartis studies combination of VOB-560 and MIK-665 for advanced hematological malignancies

July 8, 2021

AstraZeneca initiates phase I/II study of AZD-0466 in advanced hematological malignancies

July 8, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...